Our client is looking for a VP of Clinical Affairs with a specialty in heart failure to lead on their exciting next-gen Interatrial shunt with an advanced remote patient monitoring system.
The company aims to deliver advanced solutions for heart failure. They recently announced a $33.5 million in Series C financing round that will further fund product development and to initiate clinical use of the company’s adjustable interatrial shunt with integrated bi-atrial pressure monitoring.
The device includes a shunt that features a flow channel with an adaptable geometry that can be made larger or smaller post-implantation via the use of a proprietary induction catheter. In addition, the implantable device features integrated sensors designed to capture pressure readings from both the left and right atria multiple times per day without requiring patient interaction.
These daily readings can provide physicians with a more complete understanding of a patient’s hemodynamic status and can augment shunt therapy by enabling more informed medical management. Heart failure is a progressive condition that impacts approximately 6.5 million patients in the United States and as many as 26 million patients globally.
Requirements:
- Executive level experience in clinical affairs. RA or QA experience is nice to have.
- Direct experience with FIH trials all the way through larger trials for US and/or EU regulatory approval. Leadership through all phases is a plus, experience at a senior level throughout all phases is a must.
- Cardiovascular experience at a leadership level, ideally in heart failure. Interventional cardiology or HF experience is strongly preferred.
- Experience primarily in medical devices.
- Strong interpersonal skills and a savvy ability to interface with global MD KOLs is a must.
- Willingness for conference and case travel, including international travel.
- Experience with class III implantables or complex class II products preferred.
